CN104524582A - 一种基于氧化硅纳米颗粒构建多功能基因治疗载体及药物载体的方法 - Google Patents
一种基于氧化硅纳米颗粒构建多功能基因治疗载体及药物载体的方法 Download PDFInfo
- Publication number
- CN104524582A CN104524582A CN201410494297.1A CN201410494297A CN104524582A CN 104524582 A CN104524582 A CN 104524582A CN 201410494297 A CN201410494297 A CN 201410494297A CN 104524582 A CN104524582 A CN 104524582A
- Authority
- CN
- China
- Prior art keywords
- monox nanometer
- nanometer granule
- add
- granule
- mass ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000001415 gene therapy Methods 0.000 title claims abstract description 22
- 239000003937 drug carrier Substances 0.000 title claims abstract description 20
- 239000002105 nanoparticle Substances 0.000 title abstract description 10
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical compound [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 title abstract 12
- 239000003814 drug Substances 0.000 claims abstract description 29
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 claims abstract description 15
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000008187 granular material Substances 0.000 claims description 73
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 239000003999 initiator Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000000377 silicon dioxide Substances 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 14
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 13
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 13
- 238000001354 calcination Methods 0.000 claims description 13
- 238000005119 centrifugation Methods 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 12
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 10
- 239000000178 monomer Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 4
- 229920000428 triblock copolymer Polymers 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- UKODFQOELJFMII-UHFFFAOYSA-N pentamethyldiethylenetriamine Chemical compound CN(C)CCN(C)CCN(C)C UKODFQOELJFMII-UHFFFAOYSA-N 0.000 claims description 3
- SNGREZUHAYWORS-UHFFFAOYSA-N perfluorooctanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SNGREZUHAYWORS-UHFFFAOYSA-N 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 229910000077 silane Inorganic materials 0.000 claims description 3
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 241000233803 Nypa Species 0.000 claims description 2
- 235000005305 Nypa fruticans Nutrition 0.000 claims description 2
- 208000006011 Stroke Diseases 0.000 claims description 2
- 239000006227 byproduct Substances 0.000 claims description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims description 2
- 150000003457 sulfones Chemical class 0.000 claims description 2
- 150000003462 sulfoxides Chemical class 0.000 claims description 2
- 101710141544 Allatotropin-related peptide Proteins 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 18
- 238000001890 transfection Methods 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 11
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 8
- 230000003013 cytotoxicity Effects 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 6
- 239000000969 carrier Substances 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 5
- 230000004048 modification Effects 0.000 abstract description 5
- 238000012986 modification Methods 0.000 abstract description 5
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 abstract description 5
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 abstract description 3
- 108700005077 Viral Genes Proteins 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 2
- 238000010276 construction Methods 0.000 abstract 1
- 238000007306 functionalization reaction Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 21
- 229910052814 silicon oxide Inorganic materials 0.000 description 14
- 230000000694 effects Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 229920002873 Polyethylenimine Polymers 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940041181 antineoplastic drug Drugs 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 108091061960 Naked DNA Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000702421 Dependoparvovirus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000013335 mesoporous material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920000962 poly(amidoamine) Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 238000007445 Chromatographic isolation Methods 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012637 gene transfection Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000010550 living polymerization reaction Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 239000002127 nanobelt Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical class CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
Landscapes
- Silicon Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410494297.1A CN104524582B (zh) | 2014-09-24 | 2014-09-24 | 一种基于氧化硅纳米颗粒构建多功能基因治疗载体及药物载体的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410494297.1A CN104524582B (zh) | 2014-09-24 | 2014-09-24 | 一种基于氧化硅纳米颗粒构建多功能基因治疗载体及药物载体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104524582A true CN104524582A (zh) | 2015-04-22 |
CN104524582B CN104524582B (zh) | 2017-10-10 |
Family
ID=52840331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410494297.1A Active CN104524582B (zh) | 2014-09-24 | 2014-09-24 | 一种基于氧化硅纳米颗粒构建多功能基因治疗载体及药物载体的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524582B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107569682A (zh) * | 2017-08-03 | 2018-01-12 | 福建医科大学孟超肝胆医院 | 一种光响应性氧化硅纳米载体及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101139426A (zh) * | 2007-07-31 | 2008-03-12 | 清华大学 | 一种在纳米二氧化硅表面接枝环境响应性高分子的方法 |
CN102552942A (zh) * | 2011-11-09 | 2012-07-11 | 上海师范大学 | 一种对外界温度或pH值响应的磁性介孔纳米复合材料及其制备方法和应用 |
CN102775566A (zh) * | 2012-08-15 | 2012-11-14 | 新疆维吾尔自治区分析测试研究院 | 加替沙星分子印迹聚合物及该聚合物的制备方法 |
CN103667241A (zh) * | 2012-09-18 | 2014-03-26 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种毛发状亲水聚合物杂化磁性颗粒固定化蛋白酶及其制备方法 |
-
2014
- 2014-09-24 CN CN201410494297.1A patent/CN104524582B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101139426A (zh) * | 2007-07-31 | 2008-03-12 | 清华大学 | 一种在纳米二氧化硅表面接枝环境响应性高分子的方法 |
CN102552942A (zh) * | 2011-11-09 | 2012-07-11 | 上海师范大学 | 一种对外界温度或pH值响应的磁性介孔纳米复合材料及其制备方法和应用 |
CN102775566A (zh) * | 2012-08-15 | 2012-11-14 | 新疆维吾尔自治区分析测试研究院 | 加替沙星分子印迹聚合物及该聚合物的制备方法 |
CN103667241A (zh) * | 2012-09-18 | 2014-03-26 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种毛发状亲水聚合物杂化磁性颗粒固定化蛋白酶及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107569682A (zh) * | 2017-08-03 | 2018-01-12 | 福建医科大学孟超肝胆医院 | 一种光响应性氧化硅纳米载体及其制备方法 |
CN107569682B (zh) * | 2017-08-03 | 2020-06-23 | 福建医科大学孟超肝胆医院(福州市传染病医院) | 一种光响应性氧化硅纳米载体及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104524582B (zh) | 2017-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharma et al. | Nanogel—an advanced drug delivery tool: Current and future | |
Mu et al. | Unsaturated nitrogen-rich polymer poly (l-histidine) gated reversibly switchable mesoporous silica nanoparticles using “graft to” strategy for drug controlled release | |
Yang et al. | Surface-engineered dendrimers in gene delivery | |
Huo et al. | Redox-responsive polymers for drug delivery: from molecular design to applications | |
Bai et al. | Cylindrical polymer brushes-anisotropic unimolecular micelle drug delivery system for enhancing the effectiveness of chemotherapy | |
Li et al. | Chitosan stabilized Prussian blue nanoparticles for photothermally enhanced gene delivery | |
Zhu et al. | Supramolecular self-assembly of inclusion complexes of a multiarm hyperbranched polyether with cyclodextrins | |
Wang et al. | NIR-light-and pH-responsive graphene oxide hybrid cyclodextrin-based supramolecular hydrogels | |
Chen et al. | Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy | |
Yang et al. | Acid-labile poly (glycidyl methacrylate)-based star gene vectors | |
Li et al. | Ammonium salt modified mesoporous silica nanoparticles for dual intracellular-responsive gene delivery | |
Hu et al. | Versatile types of polysaccharide-based supramolecular polycation/pDNA nanoplexes for gene delivery | |
Thapa et al. | Small hydrophobe substitution on polyethylenimine for plasmid DNA delivery: Optimal substitution is critical for effective delivery | |
Zhang et al. | PEI grafted hyperbranched polymers with polyglycerol as a core for gene delivery | |
CN105199400A (zh) | 一种β-环糊精修饰的聚酰胺-树状大分子及其纳米金颗粒复合物的制备方法 | |
CN105362251A (zh) | DOTAP-mPEG-PLA纳米粒及其纳米粒溶液、载药复合物和制备方法和应用 | |
Adeli et al. | Thermo-and pH-sensitive dendrosomes as bi-phase drug delivery systems | |
Opanasopit et al. | Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes | |
Ahmad et al. | Chitosan based nanocomposites for drug, gene delivery, and bioimaging applications | |
CN110859823A (zh) | 光热敏感型羧甲基壳聚糖纳米载药微球及其制备方法 | |
Chis et al. | Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy | |
Su et al. | Supramolecular Host–Guest Interaction-Enhanced Adjustable Drug Release Based on β-Cyclodextrin-Functionalized Thermoresponsive Porous Polymer Films | |
Salekdeh et al. | Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: a promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine | |
CN109111575A (zh) | 一种金属-有机框架纳米颗粒的制备方法和应用 | |
Zhang et al. | Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190620 Address after: 246000 No. 88 Weisan Road, Daguan District, Anqing City, Anhui Province Patentee after: Anhui Zesheng Technology Co.,Ltd. Address before: 100029 Beijing University of Chemical Technology, 15 North Third Ring Road, Beijing, Chaoyang District Patentee before: Beijing University of Chemical Technology |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 246000 No. 88 Weisan Road, Daguan District, Anqing City, Anhui Province Patentee after: Anhui Zesheng Technology Co.,Ltd. Address before: 246000 No. 88 Weisan Road, Daguan District, Anqing City, Anhui Province Patentee before: Anhui Zesheng Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |